SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-283766
Filing Date
2022-11-14
Accepted
2022-11-14 08:05:58
Documents
17
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 6-K d388895d6k.htm 6-K 10085
2 EX-99.1 d388895dex991.htm EX-99.1 23148
3 GRAPHIC g388895dsp004.jpg GRAPHIC 173135
4 GRAPHIC g388895dsp005.jpg GRAPHIC 253534
5 GRAPHIC g388895dsp006.jpg GRAPHIC 214973
6 GRAPHIC g388895dsp007.jpg GRAPHIC 226301
7 GRAPHIC g388895dsp008.jpg GRAPHIC 218377
8 GRAPHIC g388895dsp009.jpg GRAPHIC 239145
9 GRAPHIC g388895dsp010.jpg GRAPHIC 210427
10 GRAPHIC g388895dsp011.jpg GRAPHIC 185210
11 GRAPHIC g388895dsp012.jpg GRAPHIC 239008
12 GRAPHIC g388895dsp013.jpg GRAPHIC 256344
13 GRAPHIC g388895dsp014.jpg GRAPHIC 184025
14 GRAPHIC g388895dsp015.jpg GRAPHIC 239030
15 GRAPHIC g388895dsp016.jpg GRAPHIC 234568
16 GRAPHIC g388895dsp017.jpg GRAPHIC 161646
17 GRAPHIC g388895dsp018.jpg GRAPHIC 136985
  Complete submission text file 0001193125-22-283766.txt   4406294
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 221380468
SIC: 2834 Pharmaceutical Preparations